Other languages Co-Diagnostics, Inc.

Equities

CODX

US1897631057

Market Closed - Nasdaq Other stock markets 16:00:00 2024-06-27 EDT			5-day change	1st Jan Change
1.27 ^USD	-4.51%		-12.41%	-4.51%

06-14	Co-Diagnostics, Inc. Submits First FDA 510(k) Application for Co-Dx PCR Pro Platform	CI
05-13	HC Wainwright Adjusts Price Target on Co-Diagnostics to $2 From $2.50, Maintains Neutral Rating	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Co-Diagnostics, Inc. Submits First FDA 510(k) Application for Co-Dx PCR Pro Platform	06-14
Co-Diagnostics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	05-09
Co-Diagnostics, Inc. Inaugurates New Manufacturing Facility in Utah with Ribbon Cutting Event	04-12
Co-Diagnostics, Inc. Appoints Executive Appointments	04-04
Co-Diagnostics, Inc. Appoints Richard Abbott as President	03-15
Co-Diagnostics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	03-14
Co-Diagnostics Gets Approval From India's Central Drugs Standard Control Organization For Manufacturing, Sale of Influenza Multiplex Test	03-07
Co-Diagnostics Submits PCR COVID-19 Test and PCR Pro Instrument for FDA Review	12-27
Co-Diagnostics, Inc. Completes Submission to FDA for Co-Dx PCR Pro	12-27
Co-Diagnostics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-09
Co-Diagnostics, Inc. Appoints Ivory Chang as Chief Regulatory Affairs Officer	23-08-29
Co-Diagnostics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-10
Co-Diagnostics Wins Gates Foundation Grants for Tuberculosis, HPV Tests	23-07-18
Co-Diagnostics, Inc. Announces Recent Grant Awards	23-07-18
Co-Diagnostics Receives $1.2 Million in New Funds From National Institutes of Health	23-07-13
Co-Diagnostics, Inc. Receives Funding for Co-Dx PCR Home Platform from NIH RADx Tech Program	23-07-13
Co-Diagnostics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-11
Sector Update: Health Care Stocks Slip Pre-Bell Friday	23-03-17
Co-Diagnostics Files $150 Million Mixed Shelf	23-03-17
Co-Diagnostics, Inc. Initiates Clinical Evaluations for At-Home and Point-of-Care Co Dx PCR Home(TM) Platform	23-02-22

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Co-Diagnostics, Inc.

Equities

CODX

US1897631057

Other languages

Filters